Adamas Pharmaceuticals Stock Price - ADMS

0.00 (0.0%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Adamas Pharmaceuticals Inc ADMS NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 2.69 0.00 0.00 0.00 2.69 07:00:36
Bid Price Ask Price Spread Spread % News
2.61 2.88 0.27 9.38% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 2.69 USD

Adamas Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 75.75M 28.16M 27.14M $ 54.64M $ - -3.80 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 5.00 3.60%

more financials information »

Adamas Pharmaceuticals News

Date Time Source News Article
5/13/202009:15GlobeNewswire Inc.Adamas announces issuance of new U.S. patent for GOCOVRI in..
5/08/202018:46GlobeNewswire Inc.Adamas Announces New Employment Inducement Grant
5/07/202016:11Edgar (US Regulatory)Current Report Filing (8-k)
5/07/202016:04Edgar (US Regulatory)Quarterly Report (10-q)
5/07/202016:03GlobeNewswire Inc.Adamas Reports First Quarter 2020 Financial Results
4/27/202016:03GlobeNewswire Inc.Adamas to Announce First Quarter 2020 Financial Results and..
4/23/202016:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADMS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.982.982.612.79303,957-0.29-9.73%
1 Month3.363.482.432.84400,996-0.67-19.94%
3 Months3.503.681.902.87333,156-0.81-23.14%
6 Months6.037.451.904.27496,127-3.34-55.39%
1 Year4.717.781.904.82468,966-2.02-42.89%
3 Years16.3944.001.9017.51631,971-13.70-83.59%
5 Years17.77644.001.9017.75464,718-15.09-84.87%

Adamas Pharmaceuticals Description

Adamas Pharmaceuticals Inc discovers, develops, and sells therapies for chronic neurologic disorders. The company's approved/commercial product is GOCOVRI, an amantadine therapy for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease. It operates in one reportable segment: the development and commercialization of therapeutics targeting chronic disorders of the central nervous system. The company generates its revenues primarily from the United States.
Your Recent History
Adamas Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200602 12:07:29